BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Giotta Lucifero A, Luzzi S. Against the Resilience of High-Grade Gliomas: The Immunotherapeutic Approach (Part I). Brain Sci 2021;11:386. [PMID: 33803885 DOI: 10.3390/brainsci11030386] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Li T, Fu W, Lei C, Hu S. Current status of anti-EGFR agents. Novel Sensitizing Agents for Therapeutic Anti-EGFR Antibodies 2023. [DOI: 10.1016/b978-0-12-821584-5.00027-4] [Reference Citation Analysis]
2 Giotta Lucifero A, Luzzi S. Brain AVMs-Related microRNAs: Machine Learning Algorithm for Expression Profiles of Target Genes. Brain Sci 2022;12. [PMID: 36552089 DOI: 10.3390/brainsci12121628] [Reference Citation Analysis]
3 Giotta Lucifero A, Luzzi S. Emerging immune-based technologies for high-grade gliomas. Expert Rev Anticancer Ther 2022. [PMID: 35924820 DOI: 10.1080/14737140.2022.2110072] [Reference Citation Analysis]
4 Giotta Lucifero A, Luzzi S. Immune Landscape in PTEN-Related Glioma Microenvironment: A Bioinformatic Analysis. Brain Sciences 2022;12:501. [DOI: 10.3390/brainsci12040501] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Depietri G, Carli N, Sica A, Oliviero D, Costagliola G, Striano P, Bonuccelli A, Frisone F, Peroni D, Consolini R, Foiadelli T, Orsini A. Therapeutic aspects of Sydenham's Chorea: an update. Acta Biomed 2022;92:e2021414. [PMID: 35441610 DOI: 10.23750/abm.v92iS4.12663] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Giotta Lucifero A, Luzzi S. Against the Resilience of High-Grade Gliomas: Gene Therapies (Part II). Brain Sci 2021;11:976. [PMID: 34439595 DOI: 10.3390/brainsci11080976] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
7 Giotta Lucifero A, Baldoncini M, Bruno N, Galzio R, Hernesniemi J, Luzzi S. Shedding the Light on the Natural History of Intracranial Aneurysms: An Updated Overview. Medicina (Kaunas) 2021;57:742. [PMID: 34440948 DOI: 10.3390/medicina57080742] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
8 Giotta Lucifero A, Baldoncini M, Brambilla I, Rutigliano M, Savioli G, Galzio R, Campero A, Lawton MT, Luzzi S. Gene Polymorphisms Increasing the Risk of Intracranial Aneurysms: Interleukin-6 -174G>C and -572G>C (Part II). Acta Biomed 2022;92:e2021420. [PMID: 35441611 DOI: 10.23750/abm.v92iS4.12669] [Reference Citation Analysis]
9 Michev A, Orsini A, Santi V, Bassanese F, Veraldi D, Brambilla I, Marseglia GL, Savasta S, Foiadelli T. An Overview of The Role of Tumor Necrosis Factor-Alpha in Epileptogenesis and Its Terapeutic Implications. Acta Biomed 2022;92:e2021418. [PMID: 35441606 DOI: 10.23750/abm.v92iS4.12667] [Reference Citation Analysis]
10 Orsini A, Bernasconi S, Bianchi MC, Trivelli I, Menconi MC, Nardi M, Santangelo A, Casazza G, Carli N, Esposito MG, Peroni D, Striano P, Foiadelli T, Bonuccelli A. PRES-like leukoencephalopathy presenting with status epilepticus associated with Brentuximab Vedotin treatment. Acta Biomed 2022;92:e2021416. [PMID: 35441608 DOI: 10.23750/abm.v92iS4.12665] [Reference Citation Analysis]
11 Giotta Lucifero A, Baldoncini M, Foiadelli T, Brambilla I, Savioli G, Galzio R, Campero A, Lawton MT, Luzzi S. Gene Polymorphisms Increasing the Risk of Intracranial Aneurysms: Interleukin-1β -511C>T (Part I). Acta Biomed 2022;92:e2021419. [PMID: 35441612 DOI: 10.23750/abm.v92iS4.12668] [Reference Citation Analysis]